BPC-157 5mg + TB 5mg - 10mg Vial

Sold out
BPC-157 5mg + TB 5mg - 10mg Vial
A$112.00

BPC-157 5mg + TB-500 mg – 10 mg

Compound Class: Synthetic peptides (BPC-157: pentadecapeptide; TB-500: Thymosin Beta-4 derivative)


Research Focus: Tissue repair, regeneration, and cell signalling (preclinical)

 

This combined vial contains 5 mg of BPC-157 and 5 mg of TB-500, formulated for research and educational applications.

  • BPC-157 has been studied in animal and cellular models for its role in angiogenesis, inflammation modulation, and connective tissue signalling.

  • TB-500 has been investigated in preclinical studies for its effects on cell migration, tissue regeneration, angiogenesis, and wound repair.

To date, no high-quality randomized controlled trials in humans have been published for either peptide.

Evidence Status: Preclinical research only

Selected Peer-Reviewed References:

  • Sikiric P et al. Stable Gastric Pentadecapeptide BPC-157 in Experimental Models. Current Pharmaceutical Design.

  • Vasireddi N et al. Systematic Review of BPC-157 in Orthopaedic Research.

  • Goldstein AL et al. Thymosin Beta-4: Structure, Function, and Therapeutic Potential. Annals of the New York Academy of Sciences.

  • Malinda KM et al. Thymosin Beta-4 Promotes Angiogenesis and Tissue Repair in Experimental Models. FASEB Journal.

Intended Use: For research, laboratory, or educational purposes only. Not for human consumption or therapeutic use.

Disclaimer: This product is supplied solely for educational and preclinical research applications. It is not intended for injection, treatment, or medical use. Users must comply with all applicable local laws and safety guidelines.